Altamira Therapeutics Ltd.
EARS
NASDAQ Capital Market3.05
USD
-0.05
- -
Total Valuation
Altamira Therapeutics Ltd. carries a market capitalization of 4.21M, placing it among publicly traded companies globally.
| Market Cap | 4.21M |
| Enterprise Value | N/A |
Stock Price Statistics
Altamira Therapeutics Ltd.'s stock has gained approximately 160.25641% over the past 52 weeks. The 50-day moving average sits at 3.25, while the 200-day moving average is 3.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 160.25641% |
| 50-Day Moving Average | 3.25 |
| 200-Day Moving Average | 3.40 |
| Average Volume (20 Days) | N/A |
Stock Splits
Altamira Therapeutics Ltd.'s most recent stock split took place on May 1, 2019 with a 20:1 split ratio.
| Last Split Date | 5/1/2019 |
| Split Ratio | 20:1 |